These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10909623)

  • 1. [Therapeutic approach to motor fluctuation in patients with Parkinson disease].
    Schwartz M; Scharf B
    Harefuah; 1998 May; 134(9):723-6. PubMed ID: 10909623
    [No Abstract]   [Full Text] [Related]  

  • 2. Motor fluctuations in Parkinson's disease.
    Weiner WJ
    Rev Neurol Dis; 2006; 3(3):101-8. PubMed ID: 17047575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease.
    Timmermann L; Wojtecki L; Gross J; Lehrke R; Voges J; Maarouf M; Treuer H; Sturm V; Schnitzler A
    Mov Disord; 2004 Nov; 19(11):1328-33. PubMed ID: 15389990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apomorphine: a rapid rescue agent for the management of motor fluctuations in advanced Parkinson disease.
    Kolls BJ; Stacy M
    Clin Neuropharmacol; 2006; 29(5):292-301. PubMed ID: 16960475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parkinson disease therapy: how great is the progress? Possibilities, limitations and future prospects?].
    Schulz-Hanke I
    Dtsch Med Wochenschr; 2003 Dec; 128(51-52):2689-90. PubMed ID: 14725284
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
    Lee WY; Yoon WT; Shin HY; Jeon SH; Rhee PL
    Mov Disord; 2008 Sep; 23(12):1696-700. PubMed ID: 18649391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].
    Hironishi M; Miwa H; Kondo T
    No To Shinkei; 2002 Feb; 54(2):127-32. PubMed ID: 11889758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and treatment of response fluctuations in Parkinson's disease: review article.
    Verhagen Metman L
    Amino Acids; 2002; 23(1-3):141-5. PubMed ID: 12373528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treating patients with Parkinson,s disease is a specialty: Parkinson,s disease - an abundant set of symptoms].
    Worm Petersen J
    Sygeplejersken; 1974 Dec; 74(49):4-5. PubMed ID: 4499105
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease. New treatments, still no cure.
    Mayo Clin Health Lett; 2001 May; 19(5):1-3. PubMed ID: 11349631
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's disease.
    DeLong M
    Neurobiol Dis; 2000 Oct; 7(5):559-60. PubMed ID: 11042077
    [No Abstract]   [Full Text] [Related]  

  • 16. Motor fluctuations in Parkinson's disease.
    Crabb L
    Prof Nurse; 2000 Jan; 15(4):273-7. PubMed ID: 10983145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic stimulation in Parkinson disease: with or without anesthesia?
    Maltête D; Navarro S; Welter ML; Roche S; Bonnet AM; Houeto JL; Mesnage V; Pidoux B; Dormont D; Cornu P; Agid Y
    Arch Neurol; 2004 Mar; 61(3):390-2. PubMed ID: 15023817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of levodopa-induced motor complications.
    Stocchi F; Tagliati M; Olanow CW
    Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced Parkinson's disease: an evidence-based analysis.
    Goetz CG
    Adv Neurol; 2003; 91():213-28. PubMed ID: 12442680
    [No Abstract]   [Full Text] [Related]  

  • 20. Global Mobility Task: index for evaluating motor impairment and motor rehabilitation programs in Parkinson's disease patients.
    Peppe A; Ranaldi A; Chiavalon C; Gasbarra A; Collepardo A; Romeo R; Pasqualetti P; Caltagirone C
    Acta Neurol Scand; 2007 Sep; 116(3):182-9. PubMed ID: 17714332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.